Amneal Pharmaceuticals (AMRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
The National Pharmacy Association (NPA ... beating its benchmark by 150 percentage points (see more details here). Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) develops and distributes affordable ...
In this article, we are going to take a look at where Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) stands against the other diabetes stocks. About 422 million people worldwide have diabetes ...
Sandoz Inc.'s proposed copies of Crexont infringe 12 patents for the Parkinson’s disease treatment, two Amneal Pharmaceuticals Inc. units said in the first federal infringement lawsuit over the drug ...
If you’re on the fence about investing in Amneal Pharmaceuticals, Inc., Supernus Pharmaceuticals or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors ...